国产在线一区二区三区AV,国产AV天堂无码一区二区三区,黄色电影免费观看,国内精品久久久久久99蜜桃

Stock(600222)Hot line:010-61006450

MAH

Leader of "0" Cost MAH 3.0 Era

Platform Overview

Platform Overview
————???????—???????—???????—???????—???????—???????—

 
The project Initiation service platform has more than 20 professional knowledge personnel, all from Shenyang Pharmaceutical University, Chinese Academy of Medical Sciences, Peking Union Medical College and other well-known universities at home and abroad, and has set up generic drug project strategy center, clinical & pharmacology center, intellectual property center, big data analysis center, international new product strategy center, based on the all-round analysis of the pharmaceutical industry and combined with the company's own differentiated positioning, can provide customers with personalized information technology services and comprehensive information assurance.

 Service Content

—???????—???????—???????—???????—???????—???????—???????—???????—???????—

1) Generic Drug Project Initiation: Project development risk assessment is carried out through comprehensive analysis of listed product information, including review overview, patents, market prospects, competition pattern, technical barriers, policy dynamics and other mainstream regulatory countries in Europe, the United States, Japan, China, Canada, Australia and other mainstream regulatory countries.
???????

2)Improvement and Innovation Projects: According to the domestic clinical needs and the guidance of policies and regulations, look for potential improvement and innovation projects, conduct comprehensive research from the aspects of product clinical positioning, market value, competition dynamics, patent layout, and development and listing paths of such projects at home and abroad, determine the adequacy and feasibility of the basis for the topic, and conduct in-depth pharmaceutical technology evaluation, clinical evaluation, development cycle and cost evaluation of the proposed development project.
 

3) Strategy Consulting Service: According to the needs of enterprises, provide partners with product pipeline sustainable development planning, feasibility analysis of new entry fields, and R&D strategy formulation after policy changes, such as the development opportunities and challenges in the cardiovascular field, the key points of improved new drug technology research and development, the analysis of the clinical drug competition pattern of platforms (ophthalmic preparations, enteric-coatedpreparations, sustained-release preparations), and the monthly analysis report of CDE application acceptance products.
 

4)Patent Service: Patent layout of cooperation projects, patent risk assessment of new products, infringement analysis and circumvention strategies, patent search and analysis service, patent tracking and early warning analysis.

5)Resource sharing: The leadingpharm information department cooperates with many well-known pharmaceutical databases at home and abroad (cortellis, intranet, insight, wisdombud), which can provide domestic and foreign listing information, the latest information on industry policies, new products/targets at home and abroad, domestic and foreign product sales and forecast data, market access, clinical guidelines and clinical front-line drug consultation, etc.


 

 

 

 

 

 

 

久久99亚洲精品久久久久| 99久久亚洲精品日本无码| 45分钟做受片免费观看| 欧美毛片免费观看| 日本丰满人妻XXXXXHD| 国产性做爰片免费视频看| 中国新疆xxxxxl19免费看| 欧美另类VIVOX21老少配| 精品少妇一区二区三区A片| 国产精品扒开腿做爽爽爽a片| 国产精品久久久久av福利动漫| 欧美日韩在线播放二区| 国产精品久久久久久精品毛片| jizz国产精品网站| 欧美十大艳星| 人妻斩り56歳无码| 日本少妇人妻xxxxx18| 久久国产免费观看精品3| 久久精品亚洲中文字幕无码网站 | 免费看片a级毛片免费看| 日本欧美大码一区二区免费看| 国产精品日本无码久久一老A | 亚洲一区域二区域三区域四区域| 一本久道久久综合狠狠躁| 久久综合九色综合欧美狠狠| 久久偷看各类WC女厕嘘嘘偷窃| 97人妻无码av碰碰视频| 亚洲欧美一区二区三区| 99久久久免费精品国产| 亚洲熟妇无码久久精品| 花蝴蝶日本视频免费高清| 亚洲av无码精品色午夜果冻不卡| 成年美女黄网站色大片免费看| 怡红院a∨人人爰人人爽| 99久久国产露脸国语对白| 亚洲AV片不卡无码久久| 亚洲精品无码久久久久y| 免费a级毛片18禁网站app| 玖玖热麻豆国产精品视频| 亚洲av无码av日韩av网站| 国产欧美精品123区发布|